Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Hazardous Materials|June 15, 2026
DDRGK1-mediated UFMylation regulates DEHP-induced ER-phagy and ER-stress: Implication in the hippocampal neuronal apoptosis and cognitive deficitsJunhong Geng, Luyang Cao, Chaofang Ni, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2025
Biovision-Inspired Perovskite Intelligent Camera for Panchromatic and Metameric SensingYu Li, Zikun Jin, Yujin Liu, et al.
Diabetes, Obesity & Metabolism|February 1, 2024
A meta-analysis of diabetes risk prediction models applied to prediabetes screeningYujin Liu, Sunrui Yu, Wenming Feng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 8, 2024
Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG-3 and PD-L1Lishu Zhao, Jianxian Ge, Ruru Zhang, et al.
Aging|July 28, 2020
MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axisYujin Liu, Feng Zhu, Huarong Li, et al.
International Immunopharmacology|November 7, 2017
Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathwayQianyun Chen, Xueyun Duan, Heng Fan, et al.
BMC Pulmonary Medicine|December 19, 2024
What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysisWengang Zhang, Xinyu Zhang, Wencheng Zhao, et al.
International Immunopharmacology|June 23, 2018
Over-expressed miRNA-200b ameliorates ulcerative colitis-related colorectal cancer in mice through orchestrating epithelial-mesenchymal transition and inflammatory responses by channel of AKT2Shuangjiao Deng, Hongfei Wang, Heng Fan, et al.
BMC Medicine|April 5, 2026
Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trialMaoying Guan, Wencheng Zhao, Wengang Zhang, et al.
Translational Lung Cancer Research|June 15, 2026
Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction modelHao Wang, Li Ye, Xinyue Liu, et al.
Pageof 9